| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1048555164 |
| P356 | DOI | 10.1007/S00393-011-0755-0 |
| P698 | PubMed publication ID | 21863467 |
| P50 | author | Stefan Kleinert | Q80260007 |
| P2093 | author name string | K Krueger | |
| P2860 | cites work | Statins for the primary prevention of cardiovascular disease | Q24234813 |
| Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis | Q24601392 | ||
| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 | ||
| Autoantibodies and the risk of cardiovascular events | Q33721605 | ||
| Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity | Q34238357 | ||
| Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison | Q34582722 | ||
| 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q34636529 | ||
| Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease | Q34684331 | ||
| The autoantibody rheumatoid factor may be an independent risk factor for ischaemic heart disease in men | Q36025658 | ||
| Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 | ||
| Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register | Q36732112 | ||
| Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study | Q36757060 | ||
| Effect of rheumatoid factor on mortality and coronary heart disease | Q36843049 | ||
| Non-steroidal anti-inflammatory drug use does not appear to be associated with increased cardiovascular mortality in patients with inflammatory polyarthritis: results from a primary care based inception cohort of patients. | Q37079259 | ||
| Hypertension in rheumatoid arthritis. | Q37158219 | ||
| Rheumatoid arthritis and smoking: putting the pieces together | Q37350863 | ||
| Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions | Q37415092 | ||
| The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review | Q37640953 | ||
| Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis | Q37790040 | ||
| Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives | Q37812524 | ||
| Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity | Q37859676 | ||
| Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis | Q38465160 | ||
| Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study | Q39863525 | ||
| The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis | Q40053146 | ||
| HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis | Q42610707 | ||
| No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts. | Q42635206 | ||
| Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial | Q43062339 | ||
| The role of traditional cardiovascular risk factors among patients with rheumatoid arthritis | Q44401296 | ||
| Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis | Q44453472 | ||
| Cardiovascular outcomes in male veterans with rheumatoid arthritis. | Q45331961 | ||
| Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006. | Q45781042 | ||
| Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation | Q46433523 | ||
| The role of lipid metabolism in the prevention of coronary heart disease | Q46782413 | ||
| Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu | Q47849023 | ||
| Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. | Q53725487 | ||
| Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document | Q56970676 | ||
| Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study | Q79850163 | ||
| Antirheumatic drug use and the risk of acute myocardial infarction | Q80016233 | ||
| Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? | Q80800883 | ||
| [Position paper on the primary prevention of cardiovascular diseases. Current position of the 25.3.2003 Statement of the Board of the German Society of Cardiology--heart and circulatory research work commissioned by for the board by Project Group on | Q81420385 | ||
| Cardiovascular death in rheumatoid arthritis: a population-based study | Q81484761 | ||
| Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis | Q81922641 | ||
| P433 | issue | 6 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| comorbidity | Q1414874 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 464-472 | |
| P577 | publication date | 2011-08-01 | |
| P1433 | published in | Zeitschrift fuer Rheumatologie | Q15763293 |
| P1476 | title | [Cardiovascular comorbidity and its risk factors in rheumatoid arthritis] | |
| P478 | volume | 70 |
| Q50002598 | Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Württemberg |
| Q87510837 | [Collation of comorbidities: core competence of internist rheumatologists] |
| Q85589116 | [Risk of atherosclerosis mediated by inflammation in rheumatoid arthritis] |
| Q85055006 | [Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis] |
| Q87387286 | [Treatment of cardiovascular risk factors] |
Search more.